PARTI General Information Vericel Corporation is a leading provider of advanced therapies for the sports medicine and severe burn care markets. We have a highly differentiated portfolio of cell therapy and specialty biologic products that combines innovations in biology with medical technologies. We were among the first companies to achieve commercial success in the complex field of cell therapies with treatments that use tissue engineering to regenerate skin and healthy knee cartilage. We curre...
Q2 FY2026 — expected 2026-07-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012013 | EDGAR | 68K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008447 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001628280-24-007824 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001628280-23-004714 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001628280-22-003661 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001628280-21-003081 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001628280-20-002229 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001628280-19-002007 | EDGAR | — |
| 2018-03-05 | 2017-12-31 | 0001628280-18-002753 | EDGAR | — |
| 2017-03-13 | 2016-12-31 | 0001628280-17-002492 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001628280-25-049902 | EDGAR | 17K words |
| 2025-07-31 | 2025-06-30 | 0001628280-25-036859 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023496 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001628280-24-046015 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001628280-24-033905 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001628280-24-021399 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001628280-23-037583 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001628280-23-026596 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001628280-23-017039 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001628280-22-029082 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001628280-22-020355 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001628280-22-012151 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001628280-26-012003 | EDGAR | 3K words |
| 2026-01-13 | 0001140361-26-001060 | EDGAR | — |
| 2025-11-06 | 0001628280-25-049880 | EDGAR | — |
| 2025-07-31 | 0001628280-25-036854 | EDGAR | — |
| 2025-05-08 | 0001628280-25-023481 | EDGAR | — |
| 2025-05-02 | 0001140361-25-017110 | EDGAR | — |
| 2025-04-14 | 0001140361-25-013625 | EDGAR | — |
| 2025-02-27 | 0001628280-25-008444 | EDGAR | — |
| 2025-01-14 | 0001140361-25-001060 | EDGAR | — |
| 2024-11-07 | 0001628280-24-045997 | EDGAR | — |
291 total filings indexed. 259 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000887359 |
| Ticker | VCEL |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | MI |
| Website | https://www.vcel.com |
| Listed | 1997-02-04 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report